Antidepressant Use during Lactation

Journal of Human Lactation

Volumn 17, Issue 3, 2001, Pages 256-261

  Winans, Elizabeth A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antidepressants; Breast milk; Lactation

Indexed keywords

ANTIDEPRESSANT AGENT; DRUG RESIDUE;

ADULT; BREAST MILK; CHEMISTRY; DRUG EFFECT; FEMALE; HUMAN; LACTATION; METABOLISM; NEWBORN; PUERPERAL DEPRESSION; REVIEW; SAFETY;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION, POSTPARTUM; DRUG RESIDUES; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MILK, HUMAN; SAFETY;

EID: 0035436883     PISSN: 08903344     EISSN: None     Source Type: Journal    
DOI: 10.1177/089033440101700309     Document Type: Article

References (19)

1. O'Hara MW, Neunaber DJ, Zekoski EM. Prospective study of postpartum depression: prevalence, course, and predictive factors. J Abnorm Psychol. 1984;93:158-171.
2. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast feeding. Am J Psych. 1996;153:1132-1137.
3. Hatzopoulos FK, Albrecht LM. Antidepressant use during breastfeeding. J Hum Lact. 1996; 12:139-141.
4. Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentration in human milk. Pediatrics. 1992;86:676-677.
5. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry. 1993;32:1253-1255.
6. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol. 1996;36: 42-47.
7. Ohman R, Hagg S, Carleburg L. Excretion of paroxetine into breast milk. J Clin Psychiatry. 1999;60:519-523.
8. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breastmilk. Br J Clin Pharmacol. 1991;31:209.
9. Yoshida K, Smith B, Kumat RC. Fluvoxamine in breastmilk and infant development. Br J Clin Pharmacol. 1997;44:210-211.
10. Winans EA, Cohen LW. Clinically significant drug interactions in psychiatry. Psychiatr Annals. 1998;28:399-405.
11. Jensen PN, Olesen OV, Bertelsen A, et al. Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther Drug Monitoring. 1997;19:236-239.
12. Spigset O, Carleburg L, Ohman R, et al. Excretion of citalopram in breast milk. Br J Clin Pharmacol. 1997;44:295-298.
13. Wisner KL, Perel JM, Blumer J. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry. 1998;155:690-692.
14. Stowe ZN, Owens MJ, Landry J, et al. Sertraline and desmethylsertraline in human breastmilk and nursing infants. Am J Psychiatry. 1997;154:1255-1260.
15. Yapp P, Ilett KF, Kristensen JH, et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolite. Ann Pharmacother. 2000;34:1269-1272.
16. Begg EJ, Atkinson HC, Duffull SB. Prospective evaluation of a model for the prediction of milk: plasma drug concentrations from physiochemical characteristics. Br J Clin Pharmacol. 1992;33(50):1-5.
17. Briggs GG, Samson JH, Ambrose PJ, et al. Excretion of bupropion in breast milk. Ann Pharmacother. 1993;27:431-433.
18. Perry PJ, Alexander B, Liskow BI. Antidepressants. In: Psychotropic Drug Handbook. 7th ed. Washington, DC: American Psychiatric Press; 1997:183.
19. Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol. 1998;45:459-462.